Document Detail

Psychotropic drugs as inhibitors of glycerolipid biosynthesis and secretion in primary rat hepatocyte cultures.
MedLine Citation:
PMID:  20647077     Owner:  NLM     Status:  In-Data-Review    
Glycerolipid synthesis and secretion in rat hepatocyte monolayer cultures have been studied as possible endpoints in cytotoxicity assays. Ten psychotropic drugs of different structural classes were incubated with the hepatocytes at concentrations ranging from 10(-6)m to 5 x 10(-5)m and their effects on the incorporation of [(3)H]glycerol into glycerolipids and on the subsequent lipid secretion into the medium were measured. After 2-hr exposures to eight of the ten drugs, glycerolipid secretion was inhibited as a function of the drug concentration. The integrity of the plasma membrane, however, was still preserved, as no leakage of the cytosolic enzyme, lactate dehydrogenase, occurred. The incorporation of [(3)H]glycerol into the total cell-associated glycerolipid fraction was much less affected by the drugs than was the medium-associated fraction. In this model, the tricyclic antidepressants, imipramine, clomipramine and amitriptyline caused a marked inhibition of in vitro glycerolipid secretion. Chlorpromazine, thioridazine, fluperlapine, haloperidol and promazine were of intermediate potency, and clozapine and sulpiride had no inhibitory effect on glycerolipid secretion. A significant inhibition of glycerolipid secretion was also seen after exposure to low concentrations (10(-5)m) of the non-psychotropic drugs, amiodarone, perhexiline and chloroquine, indicating that the cationic amphiphilic nature of all of the drugs studied accounted for the toxic effect. The results suggest that the assessment of the inhibitory effect on glycerolipid secretion is a sensitive endpoint for cytotoxicity which, in combination with other in vitro tests (e.g. determination of protein and bile acid biosynthesis and secretion, and enzyme leakage), allows a ranking of the relative toxicity of psychotropic drugs.
U A Boelsterli; P Bouis; P Donatsch
Related Documents :
17761377 - The influence of prescription drug insurance on psychotropic and non-psychotropic drug ...
15374247 - The influence of family and social relationships on the consumption of psychotropic dru...
25221127 - Sy40-4cannabidiol: long-lasting amelioration of vulnerability states associated with re...
2884907 - Effect of acepromazine, diazepam, fentanyl-droperidol, and oxymorphone on gastroesophag...
17091617 - Detection of motor and non-motor symptoms of end-of dose wearing-off in parkinson's dis...
8585227 - Evaluation of certain veterinary drug residues in food. forty-third report of the joint...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Toxicology in vitro : an international journal published in association with BIBRA     Volume:  1     ISSN:  0887-2333     ISO Abbreviation:  Toxicol In Vitro     Publication Date:  1987  
Date Detail:
Created Date:  2010-07-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712158     Medline TA:  Toxicol In Vitro     Country:  England    
Other Details:
Languages:  eng     Pagination:  127-32     Citation Subset:  -    
Copyright Information:
Copyright © 1987. Published by Elsevier Ltd.
Sandoz Ltd, Preclinical Research, CH-4002 Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetic variation in the response of mice to xenobiotics in vitro. I. General methodology and respon...
Next Document:  Investigation of the cytotoxicity produced by generation of short-lived reactive metabolites in vitr...